Our Focus

Since the founding of the company, Idenix has been focused on the discovery and development of antivirals to treat life-threatening infectious diseases. Our scientists apply their expertise in nucleoside/nucleotide chemistry and targeted prodrug technologies to discover innovative drug candidates.

Our primary focus is on developing medicines to treat hepatitis C virus infection but we are also exploring the potential application of our expertise to new therapeutic indications.